It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 -2028
London Health Sciences Centre – (KEYNOTE 587) A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial